Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company is engaged in manufacture of generic and branded formulations and APIs.
Lupin Limited, is a listed public company incorporated on 01 March, 1983. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 200.00 cr and the total paid-up capital is INR 91.23 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
30.27%
219.5%
447.04%
11.9%
-97.04%
9.87%
8.35
13.96
12.0
8.98
21.19
-0.03
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(109)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Central Bank of India
No. of Loans: 1
Total Amount : 200.0 cr
Bank of Baroda
No. of Loans: 1
Total Amount : 100.0 cr
State Bank of India
No. of Loans: 1
Total Amount : 50.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Vinita Deshbandhu Gupta
Shareholder
|
00058631 | 23 years |
| Kmp | Vinita Deshbandhu Gupta | <HIDDEN> | 11 years |
| Director | Manju Deshbandhu Gupta
Shareholder
|
00209461 | 11 years |
| Kmp | Amit Kumar Gupta | <HIDDEN> | 0 years |
| Managing Director | Nilesh Deshbandhu Gupta
Shareholder
|
01734642 | 11 years |
| Kmp | Ramesh Swaminathan | <HIDDEN> | 5 years |
| Whole-time Director | Ramesh Swaminathan
Shareholder
|
01833346 | 4 years |
| Director | Kanwar Bir Singh Anand | 03518282 | 4 years |
| Director | Punita Kumar Sinha
Shareholder
|
05229262 | 4 years |
| Director | Jean Luc Marie Martial Belingard | 07325356 | 9 years |
| Director | Mark Daniel Mc Dade | 09037255 | 4 years |
| Director | Jeffrey Bruce Kindler | 10592395 | 1 years |
| Director | Alfonso Martin Gimenez Zulueta | 10597962 | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ZYMA PROPERTIES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| SYNCHEM PROPERTIES PRIVATE LIMITED |
Active
|
11.0 Cr | 2 | Maharashtra |
| LUPIN BIOLOGICS LIMITED |
Active
|
15.0 L | 3 | Maharashtra |
| LUPIN INVESTMENTS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| ZYMA LABORATORIES LIMITED |
Amalgamated
|
1.4 Cr | 2 | Maharashtra |
| LUPIN HOLDINGS PRIVATE LIMITED |
Amalgamated
|
13.8 Cr | 1 | Maharashtra |
| NOVAMED INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
9.5 Cr | 1 | Maharashtra |
| LUPIN INTERNATIONAL PRIVATE LIMITED |
Amalgamated
|
5.0 L | 2 | Maharashtra |
| VISIOMED INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
11.9 Cr | 1 | Maharashtra |
| RAHAS INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
13.8 Cr | 2 | Maharashtra |
| SYNCHEM INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
82.5 Cr | 1 | Maharashtra |
| ELEMENT119 LEASING AND FINANCE PRIVATE LIMITED |
Dissolved
|
2.0 Cr | 2 | Maharashtra |
| CROP TECH CHEMICALS (INDIA) PRIVATE LIMITED |
Dissolved
|
1.0 Cr | 1 | Maharashtra |
| LUPIN PROPERTIES LIMITED |
Amalgamated
|
5.2 L | 2 | Maharashtra |
| VISIOMED INVESTMENTS PRIVATE LIMITED |
Active
|
5.0 Cr | 2 | Maharashtra |
| LUPIN DIAGNOSTICS LIMITED |
Active
|
202.6 Cr | 4 | Maharashtra |
| ORGO MERCANTILE TRADERS PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| D. B. ESTATE TRADE PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| RAHAS MULTITRADE PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| BS MERC PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| NOVODIGM LIMITED |
Amalgamated
|
2.4 Cr | 2 | Gujarat |
| NOVEL CLINICAL RESEARCH (INDIA) PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
| LUPIN PHARMACARE LIMITED |
Amalgamated
|
1.1 Cr | 1 | Maharashtra |
| RAHAS MERCANTILE PRIVATE LIMITED |
Amalgamated
|
108.0 Cr | 1 | Maharashtra |
| LUPIN ATHARV ABILITY LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| LUPIN MANUFACTURING SOLUTIONS LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
| POLYNOVA INDUSTRIES LIMITED |
Active
|
23.0 Cr | 1 | Maharashtra |
| LUPIN DIGITAL HEALTH LIMITED |
Active
|
62.3 Cr | 2 | Maharashtra |
| GALAXY SURFACTANTS LTD |
Active
|
35.5 Cr | 1 | Maharashtra |
| UFO MOVIEZ INDIA LIMITED |
Active
|
38.6 Cr | 1 | Maharashtra |
| TATA CHEMICALS LIMITED |
Active
|
254.8 Cr | 1 | Maharashtra |
| BOROSIL LIMITED |
Active
|
11.9 Cr | 1 | Maharashtra |
| BHARAT FORGE LTD |
Active
|
93.1 Cr | 1 | Maharashtra |
| TATA ASSET MANAGEMENT PRIVATE LIMITED |
Active
|
26.2 Cr | 1 | Maharashtra |
| PARADIGMARQ ADVISORS PRIVATE LIMITED |
Active
|
4.5 L | 1 | Maharashtra |
| BHARAT FINANCIAL INCLUSION LIMITED |
Amalgamated
|
140.2 Cr | 1 | Maharashtra |
| EMBASSY OFFICE PARKS MANAGEMENT SERVICES PRIVATE LIMITED |
Active
|
79.1 Cr | 1 | Karnataka |
| MAHINDRA ACCELO LIMITED |
Active
|
16.6 Cr | 1 | Maharashtra |
| METAHELIX LIFE SCIENCES LIMITED |
Amalgamated
|
10.8 L | 1 | Karnataka |
| CLASSIC LEGENDS PRIVATE LIMITED |
Active
|
754.7 Cr | 1 | Maharashtra |
| JSW STEEL LIMITED |
Active
|
244.5 Cr | 1 | Maharashtra |
| ONE MOBIKWIK SYSTEMS LIMITED |
Active
|
11.4 Cr | 1 | Haryana |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Lupin Pharmaceuticals, Inc. | Usa | - | - |
| Pharma Dynamics (Proprietary) Limited | South Africa | - | - |
| Hormosan Pharma GmbH | Germany | - | - |
| Multicare Pharmaceuticals Philippines, Inc. | Philippines | - | - |
| Generic Health Pty Limited | Australia | - | - |
| Lupin Atlantis Holdings SA | Switzerland | - | - |
| Lupin Healthcare (UK) Limited | United Kingdom | - | - |
| Lupin Australia Pty Limited | Australia | - | - |
| Lupin Pharma Canada Limited | Canada | - | - |
| Lupin Mexico S.A. de C.V | Mexico | - | - |
| Bellwether Pharma Pty Limited | Australia | - | - |
| Lupin Philippines Inc. | Philippines | - | - |
| LUPIN DIAGNOSTICS LIMITED | Maharashtra | 2011 | ₹ 202.6 Cr |
| Generic Health SDN. BHD | Malaysia | - | - |
| Lupin Inc. | Usa | - | - |
| Nanomi B.V. | Netherlands | - | - |
| Laboratorios Grin, S.A. de C.V | Mexico | - | - |
| Medquimica Industria Farmaceutica LTDA | Brazil | - | - |
| Novel Laboratories, Inc., | Usa | - | - |
| Lupin Research Inc. | Usa | - | - |
| Lupin Management, Inc. | Usa | - | - |
| Lupin Europe GmbH | Germany | - | - |
| LUPIN BIOLOGICS LIMITED | Maharashtra | 2021 | ₹ 15.0 L |
| Lupin Oncology Inc. | Usa | - | - |
| Lupin Foundation | India | - | - |
| Avenue Coral Springs, LLC | Usa | - | - |
| Southern Cross Pharma Pty Limited | Australia | - | - |
| LUPIN DIGITAL HEALTH LIMITED | Maharashtra | 2021 | ₹ 62.3 Cr |
| Medisol S.A.S., France | France | - | - |
| Lymed S.A.S., France | France | - | - |
| LUPIN MANUFACTURING SOLUTIONS LIMITED | Maharashtra | 2023 | ₹ 10.0 L |
| LUPIN ATHARV ABILITY LIMITED | Maharashtra | 2023 | ₹ 10.0 L |
The incorporation date of LUPIN LIMITED is 01 March, 1983
The authorized share capital of LUPIN LIMITED is INR ₹ 200.0 Cr.
The paid-up capital of LUPIN LIMITED is INR ₹ 91.2 Cr.
The registered address of LUPIN LIMITED is Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz ( East) NA MUMBAI Mumbai City Maharashtra - 400055
The CIN number of LUPIN LIMITED is L24100MH1983PLC029442.
Expand
Delete
Collapse
See
details
